Back to search results

A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

Abroad (travel likely)RecruitingPHASE1

Conditions

Lymphoma, Non-Hodgkin's · Lymphoma, Diffuse Large B-Cell · Follicular Lymphoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Mayo Clinic - Scottsdale, Scottsdale, Arizona, United States

  • City of Hope, Duarte, California, United States

  • University of California, Los Angeles (UCLA) - Medical Center, Los Angeles, California, United States

  • University of California, San Francisco (UCSF) - Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States

  • Colorado Blood Cancer Institute, Denver, Colorado, United States

  • University of Miami - Sylvester Cancer Center, Miami, Florida, United States

  • Florida Cancer Specialists - Sarasota, Sarasota, Florida, United States

  • Emory University Hospital, Atlanta, Georgia, United States

  • Massachusetts General Hospital, Boston, Massachusetts, United States

  • Dana-Farber Cancer Institute, Boston, Massachusetts, United States

  • Mayo Clinic - Rochester, Rochester, Minnesota, United States

  • Columbia University, New York, New York, United States

  • University of Rochester, Rochester, New York, United States

  • The Ohio State University (OSU), Columbus, Ohio, United States

  • Oregon Health & Science University (OHSU), Portland, Oregon, United States

  • Sarah Cannon Research Institute, Nashville, Tennessee, United States

  • Vanderbilt University Medical Center, Nashville, Tennessee, United States

  • Texas Oncology - DFW (Sammons CC), Dallas, Texas, United States

  • Baylor College of Medicine, Houston, Texas, United States

  • University of Washington - Fred Hutchinson Cancer Center (Seattle Cancer Care Alliance), Seattle, Washington, United States

  • Froedtert Hospital and the Medical College of Wisconsin, Milwaukee, Wisconsin, United States

  • CHU de Nantes - Hotel-Dieu, Nantes, France

  • Institut Curie, Paris, France

  • CHU Bordeaux - Hopital Haut-Leveque - Centre Francois Magendie, Pessac, France

  • HCL Centre Hospitalier Lyon Sud, Pierre-Bénite, France

  • Oncopole Claudius Regaud, Toulouse, France

  • Charite Universitaetsmedizin Berlin, Berlin, Germany

  • Universitaetsklinikum Koeln (AoeR), Cologne, Germany

  • Universitaetsklinikum Essen, Essen, Germany

  • Universitaetsklinikum Frankfurt - Klinikum der Johann Wolfgang Goethe Universitaet, Frankfurt am Main, Germany

  • IRCCS Azienda Ospedaliero-Universitaria di Bologna - Policlinico di Sant Orsola, Bologna, Italy

  • Istituto Europeo di Oncologia, Milan, Italy

  • National Cancer Center Hospital East, Chiba, Japan

  • Okayama University Hospital, Okayama, Japan

  • Cancer Institute Hospital of JFCR, Tokyo, Japan

  • Pratia Onkologia Katowice, Katowice, Poland

  • Pratia MCM Krakow, Krakow, Poland

  • AIDPORT Sp. z o.o., Skorzewo, Poland

  • Instytut Hematologii i Transfuzjologii w Warszawie, Warsaw, Poland

  • Institut Catala d'Oncologia - L'Hospitalet, Barcelona, Spain

  • South Texas Accelerated Research Therapeutics (START) Madrid - Hospital Fundacion Jimenez Diaz, Madrid, Spain

  • King's College Hospital, London, United Kingdom

  • The Royal Marsden NHS Foundation Trust, London, United Kingdom

  • Nottingham City Hospital, Nottingham, United Kingdom

  • Derriford Hospital, Plymouth, United Kingdom

  • University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom

Study leads

  • Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST)

    Study Director

    Eli Lilly and Company

View source on ClinicalTrials.gov(opens in a new tab)